This implicates PPARδ as a control for global oxidative energy metabolism and suggests a mechanism by which activation of the nuclear receptor, in part, brings about its anti-diabetic and anti-obesity properties by simultaneously reducing the quantity of triglycerides and glucose in white adipose tissue and systemic metabolism as a whole. This evidence concerns the gene PPARD and obesity disorder.